2009Yaowu fenxi zazhiRequires access

HPLC-MS determination of pharmacokinetic of ondansetron in human plasma and its bioequivalence

Luo Yi

Open publisher page 1 citations

Abstract

Objectives:To establish an HPLC-MS method for determination of pharmacokinetic of ondansetron in human plasma,and to study the bioequivalence of ondansetron hydrochloride oral solution.Methods:Twenty healthy male volunteers were orally administered with a randomized and single crossover dose of ondansetron hydrochloride oral solution(test sample) and ondansetron hydrochloride tablets(reference sample)8 mg.The plasma ondansetron were quantified by HPLC-MS(SIM+).The pharmacokinetics parameters and relative bioavailability were calculated using DAS 2.0.Results:The main pharmacokinetic parameters of test and reference preparation were as followed: tmax were(1.65±0.46)h and(1.60±0.62) h,Cmax were(57.58±14.11)ng·mL-1 and(53.01±16.24)ng·mL-1,t1/2 were(3.50±0.80)h and(4.13±1.25)h,AUC(0→24)were(353.63±75.84)ng·h·mL-1 and(326.02±104.49)ng·h·mL-1.Conclusion:The results show that the two formulations are bioequivalent.The relative bioavailability of ondansetron hydrochloride oral solution is 110.9%.

About this research paper

What this paper is about

Objectives:To establish an HPLC-MS method for determination of pharmacokinetic of ondansetron in human plasma,and to study the bioequivalence of ondansetron hydrochloride oral solution.Methods:Twenty healthy male volunteers were orally administered with a randomized and single crossover dose of ondansetron hydrochloride oral solution(test sample) and ondansetron hydrochloride tablets(reference sample)8 mg.The plasma ondansetron were quantified by HPLC-MS(SIM+).The pharmacokinetics parameters and relative bioavailability were calculated using DAS 2.0.Results:The main pharmacokinetic parameters of test and reference preparation were as followed: tmax were(1.65±0.46)h and(1.60±0.62) h,Cmax were(57.58±14.11)ng·mL-1 and(53.01±16.24)ng·mL-1,t1/2 were(3.50±0.80)h and(4.13±1.25)h,AUC(0→24)were(353.63±75.84)ng·h·mL-1 and(326.02±104.49)ng·h·mL-1.Conclusion:The results show that the two formulations are bioequivalent.The relative bioavailability of ondansetron hydrochloride oral solution is 110.9%.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objectives:To establish an HPLC-MS method for determination of pharmacokinetic of ondansetron in human plasma,and to study the bioequivalence of ondansetron hydrochloride oral solution.Methods:Twenty healthy male volunteers were orally administered with a randomized and single crossover dose of ondansetron hydrochloride oral solution(test sample) and ondansetron hydrochloride tablets(reference sample)8 mg.The plasma ondansetron were quantified by HPLC-MS(SIM+).The pharmacokinetics parameters and relative bioavailability were calculated using DAS 2.0.Results:The main pharmacokinetic parameters of test and reference preparation were as followed: tmax were(1.65±0.46)h and(1.60±0.62) h,Cmax were(57.58±14.11)ng·mL-1 and(53.01±16.24)ng·mL-1,t1/2 were(3.50±0.80)h and(4.13±1.25)h,AUC(0→24)were(353.63±75.84)ng·h·mL-1 and(326.02±104.49)ng·h·mL-1.Conclusion:The results show that the two formulations are bioequivalent.The relative bioavailability of ondansetron hydrochloride oral solution is 110.9%.

Key concepts: Bioequivalence, Ondansetron, Chemistry, Bioavailability, Pharmacokinetics, Cmax, Chromatography, High-performance liquid chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
HPLC-MS determination of pharmacokinetic of ondansetron in human plasma and its bioequivalence — Research Paper | ScholarLens